Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
Holding AXSM?
Track your performance easily
See the Price Targets and Ratings of:
AXSM Analyst Ratings
Strong Buy
9 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AXSM Stock 12 Month Forecast
Average Price Target
$127.88
▲(41.98% Upside)
| Highest Price Target$180.00 | Average Price Target$127.88 | Lowest Price Target$100.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Reiterated
11/08/24
Mizuho Securities
Reiterated
11/01/24
Wells Fargo
Reiterated
10/21/24
RBC Capital
Reiterated
10/04/24
TD Cowen
Reiterated
09/16/24
Leerink Partners
Reiterated
09/15/24
H.C. Wainwright
Reiterated
09/05/24
Needham
Reiterated
09/05/24
Cantor Fitzgerald
Reiterated
09/04/24
Truist Financial
Assigned
08/06/24
Bank of America Securities
$95→$106
Buy
17.69%
Upside
Upgraded
08/06/24
Axsome Therapeutics upgraded to Buy from Neutral at BofAAxsome Therapeutics upgraded to Buy from Neutral at BofA
UBS
$107→$105
Buy
16.58%
Upside
Reiterated
08/06/24
Axsome Therapeutics (AXSM) PT Lowered to $105 at UBSUBS analyst Ashwani Verma lowered the price target on Axsome Therapeutics (NASDAQ: AXSM) to $105.00 (from $107.00) while maintaining a Buy rating.
Robert W. Baird
$112
Buy
24.35%
Upside
Reiterated
08/05/24
Buy Rating Justified by Axsome's Financial Growth and Promising Clinical Pipeline
Citi
$125
Buy
38.78%
Upside
Reiterated
07/17/24
Axsome Therapeutics: Stable Auvelity Growth and Coverage Amid New GPO Contract
Guggenheim
―
Buy
―
Assigned
06/11/24
Axsome weakness on short report a buying opportunity, says GuggenheimAxsome weakness on short report a buying opportunity, says Guggenheim
Best Analysts Covering Axsome Therapeutics
Which Analyst Should I Follow If I Want to Buy AXSM and Sell After:
1 Month
xxx
Success Rate
9/13 ratings generated profit
Average Return
-0.97%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 69.23% of your transactions generating a profit, with an average return of -0.97% per trade.
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
-3.45%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of -3.45% per trade.
1 Year
2 Years
xxx
Success Rate
15/16 ratings generated profit
Average Return
+56.49%
assigned a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 93.75% of your transactions generating a profit, with an average return of +56.49% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AXSM Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
12
12
8
9
5
Buy
18
19
24
27
20
Hold
2
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
32
31
32
36
25
Each month's total comprises the sum of three months' worth of ratings.
AXSM Financial Forecast
AXSM Stock Forecast FAQ
What is AXSM’s average 12-month price target, according to analysts?
Based on analyst ratings, Axsome Therapeutics Inc’s 12-month average price target is $127.88.
What is AXSM’s upside potential, based on the analysts’ average price target?
Axsome Therapeutics Inc has 41.98% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AXSM a Buy, Sell or Hold?
Axsome Therapeutics Inc has a consensus rating of Strong Buy which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.
What is Axsome Therapeutics Inc’s price target?
The average price target for Axsome Therapeutics Inc is $127.88. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $180.00 ,the lowest forecast is $100.00. The average price target represents 41.98% Increase from the current price of $90.07.
The highest analyst price target is $180.00 ,the lowest forecast is $100.00. The average price target represents 41.98% Increase from the current price of $90.07.
What do analysts say about Axsome Therapeutics Inc?
Axsome Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of AXSM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.